CranioSense Named MassChallenge Finalist

Image via LinkedIn from MassChallenge

February 8, 2024

CranioSense is proud to have been selected as a Finalist in the MassChallenge RESOLVE ’24 Awards, a recognition that underscores our innovation in non-invasive intracranial pressure assessment. MassChallenge is one of the world’s leading zero-equity accelerators, and this achievement places CranioSense among a select group of emerging health-tech startups driving meaningful progress. MassChallenge+1

As part of the program, CEO and Co-Founder Ryan Myers pitched CranioSense’s breakthrough cranial-biomechanics platform to a distinguished audience of industry leaders, investors, and healthcare innovators; showcasing our technology and mission to transform how brain pressure is assessed in clinical settings.

Participating in MassChallenge provided CranioSense with valuable mentorship, strategic guidance, and access to a global network of innovators. Being selected as a finalist demonstrates the momentum behind our vision for advancing brain-health diagnostics.

Learn more about the science behind our work on the Technology page, meet our leadership at the Team page, or connect with us via Contact.
You can also view the official MassChallenge finalist listing here: RESOLVE ’24 Finalists – MassChallenge